NLS Pharmaceutics Ltd. stock is down -25.36% since 30 days ago. The next earnings date is Dec 19, 2023. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 2 December’s closed higher than November.
NLS Pharmaceutics AG is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders. Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy. The company was incorporated in 2015 and is based in Zurich, Switzerland.